SXTC vs CODA vs MNDO vs SBFM vs NTCT

For growth investors, Sunshine Biopharma, Inc.

(SBFM) is the stronger pick with 44. 7% revenue growth year-over-year, versus -9. 7% for China SXT Pharmaceuticals, Inc. (SXTC). MIND C. T. I. Ltd (MNDO) offers the better valuation at 7. 6x trailing P/E, making it the more compelling value choice. Analysts rate Coda Octopus Group, Inc. (CODA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, MIND C.

T. I. Ltd (MNDO) is the cheapest at 7. 6x versus Coda Octopus Group, Inc. at 32. 7x. On forward P/E, NetScout Systems, Inc. is actually cheaper at 16. 2x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Coda Octopus Group, Inc.

(CODA) delivered a total return of +55. 9%, compared to -100. 0% for Sunshine Biopharma, Inc. (SBFM). Over 10 years, the gap is even starker: CODA returned +861. 1% versus SBFM's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), MIND C.

T. I. Ltd (MNDO) is the lower-risk stock at 0. 05β versus Sunshine Biopharma, Inc. 's 1. 33β — meaning SBFM is approximately 2476% more volatile than MNDO relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 6% for China SXT Pharmaceuticals, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sunshine Biopharma, Inc.

(SBFM) is pulling ahead at 44. 7% versus -9. 7% for China SXT Pharmaceuticals, Inc. (SXTC). On earnings-per-share growth, the picture is similar: Sunshine Biopharma, Inc. grew EPS 97. 9% year-over-year, compared to -144. 4% for NetScout Systems, Inc.. Over a 3-year CAGR, SBFM leads at 434. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Coda Octopus Group, Inc.

(CODA) is the more profitable company, earning 15. 5% net margin versus -189. 8% for China SXT Pharmaceuticals, Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CODA leads at 17. 1% versus -154. 0% for SXTC. At the gross margin level — before operating expenses — NTCT leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, NetScout Systems, Inc.

(NTCT) trades at 16. 2x forward P/E versus 22. 8x for Coda Octopus Group, Inc. — 6. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CODA: 15. 6% to $14. 00.

In this comparison, MNDO (22.

0% yield) pays a dividend. SXTC, CODA, SBFM, NTCT do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, MIND C.

T. I. Ltd (MNDO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 05), 22. 0% yield). Both have compounded well over 10 years (MNDO: +65. 7%, SBFM: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SXTC (Healthcare) and CODA (Industrials) and MNDO (Technology) and SBFM (Healthcare) and NTCT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SXTC is a small-cap quality compounder stock; CODA is a small-cap high-growth stock; MNDO is a small-cap deep-value stock; SBFM is a small-cap high-growth stock; NTCT is a small-cap quality compounder stock. MNDO pays a dividend while SXTC, CODA, SBFM, NTCT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.